FX 322: familiar with the trials on this for hearing restoration?

Is this the trial you are referring to
– FX-322 in Adults With Stable Sensorineural Hearing Loss https://clinicaltrials.gov/ct2/show/NCT04120116

I'm familiar with Frequency Therapeutics and FX-322. It is not a pill, however – it is is an intratympanic injection. The link Colleen posted is the official study page for the most recent FX-322 clinical trial, which is ongoing. Results for this study are expected to be announced in the second quarter of 2021, according to a recent August 12th press release. The topline results were originally anticipated for September 2020. Delay is due to impact of Covid19 on patient enrollment, nothing unusual given the circumstances.

@urgentresearch, thank you for clarifying. Are you involved with this research?

No, but I am involved in monitoring hearing loss clinical trials and new research and so I thought I would pass along an update 🙂

Thank you!